Think Growth. Think IPOX.
IPOX Operates at the Intersection of Asset Management, Equity Capital Markets (ECMs) and Respective Financial Products Design.
IPOX operates the IPOX® Indexes and bespoke custom portfolio solutions for investors across accessible global New Listings markets.
Deal Flow Analytics
IPOX performs independent quantitative and qualitative research to help investors in understanding the importance of New Listings.
Financial products in excess of $4 billion have been tied to IPOX Strategies, including 5-star ETFs, Mutual Funds and SMAs.
Case Study: The IPOX® 100 U.S. Index
IPOX launched the IPOX 100 U.S. Index live on August 6, 2004, one month before the Google IPO. Our goal was to apply “Indexing” to the U.S. New Listings market.
Since then, the IPOX 100 U.S. Index has become the gold standard for investors in U.S. New Listings. Since its inception through January 31, 2019, the IPOX 100 U.S. Index has more than doubled the performance of the S&P 500 Index at only slightly higher risk, underlying the asset allocation potential of New Listings as pioneered by IPOX.
Explore the Potential of New Listings Through Our Customized Products:
Talk to IPOX if you seek
- Positive Absolute Returns
- Low Correlation